Concentric Capital Strategies LP bought a new position in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 184,681 shares of the semiconductor company’s stock, valued at approximately $13,340,000. Lam Research accounts for approximately 0.6% of Concentric Capital Strategies LP’s portfolio, making the stock its 24th largest holding.
Other hedge funds have also recently added to or reduced their stakes in the company. CWA Asset Management Group LLC grew its stake in Lam Research by 994.9% during the 4th quarter. CWA Asset Management Group LLC now owns 31,720 shares of the semiconductor company’s stock valued at $2,291,000 after acquiring an additional 28,823 shares in the last quarter. Fortem Financial Group LLC boosted its position in shares of Lam Research by 928.9% during the fourth quarter. Fortem Financial Group LLC now owns 3,910 shares of the semiconductor company’s stock worth $282,000 after buying an additional 3,530 shares during the period. Diversified Trust Co lifted its position in shares of Lam Research by 8.3% during the fourth quarter. Diversified Trust Co now owns 3,741 shares of the semiconductor company’s stock worth $270,000 after purchasing an additional 286 shares in the last quarter. Stonehearth Capital Management LLC boosted its position in Lam Research by 802.3% in the 4th quarter. Stonehearth Capital Management LLC now owns 2,788 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 2,479 shares during the period. Finally, Rise Advisors LLC acquired a new position in Lam Research during the 4th quarter worth $54,000. 84.61% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, SVP Seshasayee Varadarajan sold 110,080 shares of the firm’s stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $90.00, for a total value of $9,907,200.00. Following the sale, the senior vice president now owns 179,084 shares in the company, valued at approximately $16,117,560. This trade represents a 38.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.29% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on LRCX
Lam Research Stock Down 1.0 %
Shares of NASDAQ LRCX opened at $73.16 on Wednesday. Lam Research Co. has a 52-week low of $56.32 and a 52-week high of $113.00. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. The company’s 50 day moving average price is $71.62 and its 200-day moving average price is $75.16. The company has a market capitalization of $93.58 billion, a P/E ratio of 22.22, a price-to-earnings-growth ratio of 1.47 and a beta of 1.64.
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its earnings results on Wednesday, April 23rd. The semiconductor company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. The firm had revenue of $4.72 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period last year, the firm posted $7.79 EPS. The business’s revenue was up 24.4% compared to the same quarter last year. Equities analysts forecast that Lam Research Co. will post 3.71 earnings per share for the current year.
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles
- Five stocks we like better than Lam Research
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Is Intel Stock a Bargain or a Burden? Cheap Stock, High Stakes
- Stock Dividend Cuts Happen Are You Ready?
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Why Are Stock Sectors Important to Successful Investing?
- The Top-Ranked Insider Buys From April by Market Cap
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.